Literature DB >> 25795715

WNT10A promotes an invasive and self-renewing phenotype in esophageal squamous cell carcinoma.

Apple Long1, Véronique Giroux1, Kelly A Whelan1, Kathryn E Hamilton1, Marie-Pier Tétreault1, Koji Tanaka1, Ju-Seog Lee2, Andres J Klein-Szanto3, Hiroshi Nakagawa1, Anil K Rustgi4.   

Abstract

Esophageal cells overexpressing epidermal growth factor receptor (EGFR) and TP53 mutation can invade into the extracellular matrix when grown in 3D-organotypic cultures (OTC) and mimic early invasion in esophageal squamous cell carcinoma (ESCC). We have performed laser capture microdissection with RNA microarray analysis on the invasive and non-invasive tumor cells of p53(R175H)-overexpressing OTC samples to determine candidate genes facilitating tumor invasion. WNT10A was found to be >4-fold upregulated in the invasive front. Since WNT10A is also prominently upregulated during placode promotion in hair follicle development, a process that requires epithelial cells to thicken and elongate, in order to allow downward growth, we hypothesized that WNT10A may be important in mediating a similar mechanism of tumor cell invasion in ESCC. We have found that WNT10A expression is significantly upregulated in human ESCC, when compared with normal adjacent tissue. Furthermore, high WNT10A expression levels correlate with poor survival. Interestingly, we observe that WNT10A is expressed early in embryogenesis, but is reduced dramatically postnatally. We demonstrate that overexpression of WNT10a promotes migration and invasion, and proliferation of transformed esophageal cells. Lastly, we show that WNT10A overexpression induces a greater CD44(High)/CD24(Low) population, which are putative markers of cancer stem cells, and increases self-renewal capability. Taken together, we propose that WNT10A acts as an oncofetal factor that is highly expressed and may promote proper development of the esophagus. During tumorigenesis, it is aberrantly overexpressed in order to promote ESCC migration and invasion, and may be linked to self-renewal of a subset of ESCC cells.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25795715      PMCID: PMC4498148          DOI: 10.1093/carcin/bgv025

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  52 in total

1.  Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation.

Authors:  Hideki Harada; Hiroshi Nakagawa; Kenji Oyama; Munenori Takaoka; Claudia D Andl; Birgit Jacobmeier; Alexander von Werder; Gregory H Enders; Oliver G Opitz; Anil K Rustgi
Journal:  Mol Cancer Res       Date:  2003-08       Impact factor: 5.852

Review 2.  WNT signalling in the immune system: WNT is spreading its wings.

Authors:  Frank J T Staal; Tiago C Luis; Machteld M Tiemessen
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

Review 3.  Wnt signaling in stem and cancer stem cells.

Authors:  Jane D Holland; Alexandra Klaus; Alistair N Garratt; Walter Birchmeier
Journal:  Curr Opin Cell Biol       Date:  2013-01-21       Impact factor: 8.382

4.  Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of Sonic hedgehog in hair follicle morphogenesis.

Authors:  S Reddy; T Andl; A Bagasra; M M Lu; D J Epstein; E E Morrisey; S E Millar
Journal:  Mech Dev       Date:  2001-09       Impact factor: 1.882

5.  Interactions between cancer stem cells and their niche govern metastatic colonization.

Authors:  Ilaria Malanchi; Albert Santamaria-Martínez; Evelyn Susanto; Hong Peng; Hans-Anton Lehr; Jean-Francois Delaloye; Joerg Huelsken
Journal:  Nature       Date:  2011-12-07       Impact factor: 49.962

6.  Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.

Authors:  V J Wielenga; R Smits; V Korinek; L Smit; M Kielman; R Fodde; H Clevers; S T Pals
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

7.  Expression of WNT10A in human cancer.

Authors:  H Kirikoshi; S Inoue; H Sekihara; M Katoh
Journal:  Int J Oncol       Date:  2001-11       Impact factor: 5.650

8.  Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx2.

Authors:  Nan Gao; Peter White; Klaus H Kaestner
Journal:  Dev Cell       Date:  2009-04       Impact factor: 12.270

9.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4.

Authors:  V Korinek; N Barker; P Moerer; E van Donselaar; G Huls; P J Peters; H Clevers
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

Review 10.  Wnt proteins.

Authors:  Karl Willert; Roel Nusse
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

View more
  31 in total

1.  WNT5A: a motility-promoting factor in Hodgkin lymphoma.

Authors:  F Linke; S Zaunig; M M Nietert; F von Bonin; S Lutz; C Dullin; P Janovská; T Beissbarth; F Alves; W Klapper; V Bryja; T Pukrop; L Trümper; J Wilting; D Kube
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

2.  Modeling Esophagitis Using Human Three-Dimensional Organotypic Culture System.

Authors:  Dorottya Laczkó; Fang Wang; F Bradley Johnson; Nirag Jhala; András Rosztóczy; Gregory G Ginsberg; Gary W Falk; Anil K Rustgi; John P Lynch
Journal:  Am J Pathol       Date:  2017-06-13       Impact factor: 4.307

Review 3.  Esophageal carcinoma: Towards targeted therapies.

Authors:  Ali Fatehi Hassanabad; Rania Chehade; Daniel Breadner; Jacques Raphael
Journal:  Cell Oncol (Dordr)       Date:  2019-12-17       Impact factor: 6.730

4.  Wnt signaling regulates hepatobiliary repair following cholestatic liver injury in mice.

Authors:  Hirohisa Okabe; Jing Yang; Kyle Sylakowski; Mladen Yovchev; Yoshitaka Miyagawa; Shanmugam Nagarajan; Maria Chikina; Michael Thompson; Michael Oertel; Hideo Baba; Satdarshan P Monga; Kari Nichole Nejak-Bowen
Journal:  Hepatology       Date:  2016-09-26       Impact factor: 17.425

5.  Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor.

Authors:  Atsushi Shiozaki; Michihiro Kudou; Daisuke Ichikawa; Hitoshi Fujiwara; Hiroki Shimizu; Takeshi Ishimoto; Tomohiro Arita; Toshiyuki Kosuga; Hirotaka Konishi; Shuhei Komatsu; Kazuma Okamoto; Yoshinori Marunaka; Eigo Otsuji
Journal:  J Gastroenterol       Date:  2017-04-07       Impact factor: 7.527

Review 6.  Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma.

Authors:  L K Kadian; M Arora; C P Prasad; R Pramanik; S S Chauhan
Journal:  Clin Transl Oncol       Date:  2022-01-06       Impact factor: 3.405

7.  Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines.

Authors:  Tatjana Sauerer; Christopher Lischer; Adrian Weich; Carola Berking; Julio Vera; Jan Dörrie
Journal:  Front Microbiol       Date:  2021-12-22       Impact factor: 5.640

8.  Chromatin Looping Shapes KLF5-Dependent Transcriptional Programs in Human Epithelial Cancers.

Authors:  Yanli Liu; Bingqian Guo; Estrella Aguilera-Jimenez; Vivian S Chu; Jin Zhou; Zhong Wu; Joshua M Francis; Xiaojun Yang; Peter S Choi; Swneke D Bailey; Xiaoyang Zhang
Journal:  Cancer Res       Date:  2020-10-28       Impact factor: 12.701

9.  Rab11-FIP1 mediates epithelial-mesenchymal transition and invasion in esophageal cancer.

Authors:  Qiaosi Tang; Ashley Lento; Kensuke Suzuki; Gizem Efe; Tatiana Karakasheva; Apple Long; Véronique Giroux; Mirazul Islam; E Paul Wileyto; Andres J Klein-Szanto; Hiroshi Nakagawa; Adam Bass; Anil K Rustgi
Journal:  EMBO Rep       Date:  2021-01-06       Impact factor: 8.807

10.  Diffuse Large B-Cell Lymphoma Promotes Endothelial-to-Mesenchymal Transition via WNT10A/Beta-Catenin/Snail Signaling.

Authors:  Xianting Sun; Jianchen Fang; Fen Ye; Shuxian Zhang; Honghui Huang; Jian Hou; Ting Wang
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.